Viewing StudyNCT00445588



Ignite Creation Date: 2024-05-05 @ 5:22 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00445588
Status: COMPLETED
Last Update Posted: 2016-04-27
First Post: 2007-03-07

Brief Title: Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-01
Start Date Type: None
Primary Completion Date: 2009-08
Primary Completion Date Type: ACTUAL
Completion Date: 2009-08
Completion Date Type: ACTUAL
First Submit Date: 2007-03-07
First Submit QC Date: March 7 2007
Study First Post Date: 2007-03-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2016-04-27
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-03-25
Last Update Post Date: 2016-04-27
Last Update Post Date Type: ESTIMATED